| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Turn Therapeutics Inc. | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | Common Stock | 12,500 | $43,750 | $3.50 | 12 Dec 2025 | Direct |
| Global Health Solutions, Inc | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | Employee stock option (right to buy) | 240,000 | 08 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TTRX | Turn Therapeutics Inc. | 12 Dec 2025 | 1 | +$8,750 | 4 | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | 12 Dec 2025, 18:00 |
| TTRX | Turn Therapeutics Inc. | 20 Nov 2025 | 2 | +$7,074 | 4 | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | 21 Nov 2025, 17:43 |
| TTRX | Turn Therapeutics Inc. | 17 Nov 2025 | 1 | +$9,050 | 4 | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | 17 Nov 2025, 21:23 |
| TTRX | Turn Therapeutics Inc. | 23 Oct 2025 | 1 | +$24,998 | 4 | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | 23 Oct 2025, 21:03 |
| TTRX | Turn Therapeutics Inc. | 08 Oct 2025 | 1 | $0 | 4 | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. | 10 Oct 2025, 09:42 |
| TTRX | Turn Therapeutics Inc. | 07 Oct 2025 | 0 | $0 | 3 | Officer | 07 Oct 2025, 19:13 |